Photofrin

Photofrin is a brand name of porfimer, approved by the FDA in the following formulation(s):

PHOTOFRIN (porfimer sodium - injectable; injection)

• 
  Manufacturer: PINNACLE BIOLGS
  
  Approval date: December 27, 1995
  
  Strength(s): 75MG/VIAL
  

Has a generic version of Photofrin been approved?

No. There is currently no therapeutically equivalent version of Photofrin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Photofrin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Stable porfimer sodium compositions and methods for their manufacture
  Patent 5,438,071
  Issued: August 1, 1995
  Inventor(s): Clauss; Steven L. & Pastel; Michael J. & Zawadzki; Rainer K.
  Assignee(s): American Cyanamid Company
  A storage stable porfimer sodium (polyhematoporphyrin ether/ester) composition useful in the photodynamic therapy of cancer and other conditions is provided. The composition is characterized in that the percentage of ester linked porphyrin oligomers is less than 10% of the composition. Improved processes for preparing such compositions are also provided wherein acetylated hematoporphyrin is treated with alkali for sufficient time and temperature to reduce the amount of porphyrin oligomers joined by ester linkages to less than 10% of the composition.
  
  Patent expiration dates:
  
  
  • August 1, 2012
    
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 1, 2010 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Photofrin Consumer Information (Wolters Kluwer)
• Photofrin Consumer Information (Cerner Multum)
• Photofrin Advanced Consumer Information (Micromedex)
• Porfimer Consumer Information (Wolters Kluwer)
• Porfimer Consumer Information (Cerner Multum)
• Porfimer Intravenous Advanced Consumer Information (Micromedex)